Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Giulia Natali"'
Autor:
Silvia Siragusa, Giulia Natali, Antonella Maria Nogara, Marcello Trevisani, Costanza Anna Maria Lagrasta, Silvia Pontis
Publikováno v:
Exploration of Medicine, Vol 4, Iss 6, Pp 1116-1134 (2023)
Chronic obstructive pulmonary disease (COPD) is an inflammatory lung pathology characterized by persistent airflow limitation and is the third leading cause of death globally. COPD pathophysiology includes both environmental and host risk factors and
Externí odkaz:
https://doaj.org/article/320611d6905446ec9353c8798e3feb0c
Autor:
Giulia Natali, Caterina Michetti, Alicja Krawczun-Rygmaczewska, Thomas Floss, Fabrizia Cesca, Fabio Benfenati
Publikováno v:
Frontiers in Cellular Neuroscience, Vol 17 (2023)
The repressor element-1 silencing transcription factor/neuron-restrictive silencer factor (REST/NRSF) is an epigenetic master regulator that plays a crucial role during nervous system development and maturation. REST function was originally described
Externí odkaz:
https://doaj.org/article/4596b63b2ff440ad90844cb525371eb5
Autor:
Javier Flores Gutiérrez, Claudio De Felice, Giulia Natali, Silvia Leoncini, Cinzia Signorini, Joussef Hayek, Enrico Tongiorgi
Publikováno v:
Journal of Neurodevelopmental Disorders, Vol 12, Iss 1, Pp 1-20 (2020)
Abstract Background Rett syndrome (RTT), an X-linked neurodevelopmental rare disease mainly caused by MECP2-gene mutations, is a prototypic intellectual disability disorder. Reversibility of RTT-like phenotypes in an adult mouse model lacking the Mec
Externí odkaz:
https://doaj.org/article/e9c206f504bc44938e584a685ba6c052
Rett Syndrome (RTT) is a rare X-linked neurodevelopmental disorder, mainly caused by mutations in the MECP2 gene. Reduction in monoamine levels in RTT patients and mouse models suggested the possibility to rescue clinical phenotypes through antidepre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::de9f1ecd538f7ca5638961af2644b423
https://doi.org/10.1101/2021.12.17.473107
https://doi.org/10.1101/2021.12.17.473107
Publikováno v:
Experimental neurology. 353
Rett Syndrome (RTT) is a rare X-linked neurodevelopmental disorder, mainly caused by mutations in the MECP2 gene. Reduction in monoamine levels in RTT patients and mouse models suggested the possibility to rescue clinical phenotypes through antidepre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6912263c2f6b32f5bb6fd4f8f6a9df9
https://pubmed.ncbi.nlm.nih.gov/35358499
https://pubmed.ncbi.nlm.nih.gov/35358499
Autor:
Claudio De Felice, Enrico Tongiorgi, Silvia Leoncini, Cinzia Signorini, Javier Flores Gutiérrez, Giulia Natali, Joussef Hayek
Publikováno v:
Journal of Neurodevelopmental Disorders
Journal of Neurodevelopmental Disorders, Vol 12, Iss 1, Pp 1-20 (2020)
Journal of Neurodevelopmental Disorders, Vol 12, Iss 1, Pp 1-20 (2020)
Background Rett syndrome (RTT), an X-linked neurodevelopmental rare disease mainly caused by MECP2-gene mutations, is a prototypic intellectual disability disorder. Reversibility of RTT-like phenotypes in an adult mouse model lacking the Mecp2-gene h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e0685b9fde809209707df4d11137198
https://doi.org/10.1186/s11689-020-09328-z
https://doi.org/10.1186/s11689-020-09328-z